Zhejiang Jinggong Science & Technology Co., Ltd (002006.SZ) Bundle
Investors scrutinizing Zhejiang Jinggong Science & Technology Co., Ltd. will want to weigh a mix of striking figures: Q1 2025 revenue fell to 404 million yuan (-25.93% YoY) even as first nine‑month revenue rose to 1.343 billion yuan (+13.70% YoY) and TTM revenue reached 1.89 billion yuan (+18.03% YoY); profitability shows Q1 net income of 43.46 million yuan (-24% YoY) contrasted with a 1-3Q net attributable to shareholders of 145 million yuan (+98.18% YoY) and a TTM net income of 218.65 million yuan (TTM net margin ~8.5%, EPS 0.43 yuan). Balance‑sheet and liquidity metrics include total assets of 4.05 billion yuan, total liabilities of 1.68 billion yuan (debt‑to‑equity 17.45%), total debt 443.77 million yuan, equity 2.37 billion yuan, cash and short‑term investments 1.17 billion yuan, current ratio 1.371, operating cash flow (TTM) 195.29 million yuan, free cash flow (TTM) -154.59 million yuan and net change in cash (TTM) -196.86 million yuan, while market valuation shows market cap 10.36 billion yuan with a P/E of 64.94 (forward P/E 28.47), P/S 6.02 and P/B 4.69. Growth and strategic moves cited by the company include a projected CAGR target of 15% aiming toward 8 billion yuan revenue by 2025 (from 4.5 billion in 2022), ~1 billion yuan earmarked for acquisitions, a joint venture expected to add ~300 million yuan in annual revenue, a 40% stake in Zhejiang Huachuang Carbon Fiber for 10 million yuan, a major Saudi contract worth 172 million USD, and annual R&D spending around 500 million yuan (planned +20% by 2025); risks highlighted include cyclical CAPEX exposure, intense domestic and international competition, policy dependence in solar and construction sectors, raw‑material price volatility (notably steel), and regulatory/compliance pressures.
Zhejiang Jinggong Science & Technology Co., Ltd (002006.SZ) - Revenue Analysis
Zhejiang Jinggong's recent revenue trajectory shows mixed short-term weakness and stronger multi-period growth. Key reported figures:
- Q1 2025 revenue: 404 million yuan, down 25.93% year-on-year.
- First three quarters 2025 revenue: 1.343 billion yuan, up 13.70% year-on-year.
- Full-year 2024 revenue: 1.73 billion yuan, +12.25% versus 2023 (1.54 billion yuan).
- TTM revenue as of 2025-11-05: 1.89 billion yuan, +18.03% year-on-year.
- Quarter ended 2025-09-30 revenue: 282.07 million yuan, +28.53% year-on-year.
- Company projection: targeted CAGR of 15% through 2025, aiming for ~8.0 billion yuan in revenue by 2025 (from 4.5 billion yuan in 2022).
| Period | Revenue (yuan) | YoY change |
|---|---|---|
| Q1 2025 | 404,000,000 | -25.93% |
| Q3 2025 (quarter) | 282,070,000 | +28.53% |
| Jan-Sep 2025 (YTD) | 1,343,000,000 | +13.70% |
| FY 2024 | 1,730,000,000 | +12.25% |
| FY 2023 | 1,540,000,000 | - |
| TTM (as of 2025-11-05) | 1,890,000,000 | +18.03% |
| Company target (2025) | ~8,000,000,000 | CAGR target: 15% (2022-2025) |
Interpretation points for investors:
- Short-term volatility: Q1 2025's 25.93% decline contrasts with strong Q3 growth (+28.53%), indicating uneven quarterly performance and potential seasonality or contract timing effects.
- Mid-term growth: YTD and TTM metrics (1.343bn YTD; 1.89bn TTM) imply recovery and acceleration vs. FY2024.
- Ambitious targets: the company's target to expand from 4.5bn (2022) to ~8.0bn by 2025 implies aggressive scaling; investors should assess feasibility via margin trends, capacity, and order backlog.
- Data points to monitor next: quarterly revenue cadence, backlog/repeat order rates, and segment/geography breakdowns that could explain volatility.
Further company context: Zhejiang Jinggong Science & Technology Co., Ltd: History, Ownership, Mission, How It Works & Makes Money
Zhejiang Jinggong Science & Technology Co., Ltd (002006.SZ) - Profitability Metrics
Zhejiang Jinggong Science & Technology Co., Ltd reported mixed profitability signals across 2024-2025: quarterly net income fell in Q1 2025, while cumulative results through Q3 2025 show a strong year-on-year recovery. Key headline figures:- Q1 2025 net income: ¥43.46 million (YoY -24%).
- First three quarters of 2025 net profit attributable to shareholders: ¥145 million (YoY +98.18%).
- Full-year 2024 net income: ¥146.95 million (down 18.53% from ¥180.36 million in 2023).
- TTM net income (as of 2025-11-05): ¥218.65 million.
- TTM net profit margin: ~8.5%.
- TTM EPS: ¥0.43.
| Period | Net Income (¥ million) | YoY Change | Net Profit Margin | EPS (¥) |
|---|---|---|---|---|
| Q1 2025 | 43.46 | -24% | - | - |
| First 3 quarters 2025 | 145.00 | +98.18% | - | - |
| FY 2024 | 146.95 | -18.53% | - | - |
| FY 2023 | 180.36 | - | - | - |
| TTM (as of 2025-11-05) | 218.65 | - | ~8.5% | 0.43 |
- Profitability trajectory: the TTM net income (¥218.65M) exceeds FY 2024 (¥146.95M), indicating recovery and improved trailing profitability versus the single-year 2024 decline.
- Margin context: a TTM net profit margin near 8.5% suggests moderate profitability relative to peers in manufacturing/technology; margin expansion or contraction should be monitored alongside cost structure and revenue mix.
- Per-share impact: TTM EPS of ¥0.43 reflects the improved absolute net income and is a key input for valuation and dividend considerations.
Zhejiang Jinggong Science & Technology Co., Ltd (002006.SZ) - Debt vs. Equity Structure
- Total assets (June 2025): 4.05 billion yuan
- Total liabilities (June 2025): 1.68 billion yuan
- Total debt (June 2025): 443.77 million yuan
- Total equity (June 2025): 2.37 billion yuan
- Debt-to-equity ratio (reported): 17.45%
- Cash & short-term investments (June 2025): 1.17 billion yuan
- Market capitalization (Nov 5, 2025): 10.36 billion yuan
- Price-to-book (P/B) ratio: 4.69
Key balance-sheet snapshot and implications for capital structure, liquidity and leverage:
| Metric | Value (Yuan) | Derived Ratio / Note |
|---|---|---|
| Total Assets | 4,050,000,000 | - |
| Total Liabilities | 1,680,000,000 | - |
| Total Debt | 443,770,000 | Reported total interest-bearing debt |
| Total Equity | 2,370,000,000 | - |
| Reported Debt-to-Equity | 17.45% | Company-reported metric (see note below) |
| Cash & Short-term Investments | 1,170,000,000 | High cash buffer vs. reported debt |
| Net Debt (Debt - Cash) | (726,230,000) | Net cash position: cash exceeds interest-bearing debt |
| Market Capitalization (Nov 5, 2025) | 10,360,000,000 | - |
| Price-to-Book (P/B) | 4.69 | Market valuation relative to book equity |
- Low reported leverage: company reports a debt-to-equity of 17.45% and holds a net cash position when cash is offset against interest-bearing debt.
- Liquidity cushion: cash & short-term investments (1.17 billion yuan) materially exceed total debt (443.77 million yuan), supporting near-term obligations and optionality for capex or M&A.
- Balance-sheet scale vs. market value: with equity of 2.37 billion yuan and market cap of 10.36 billion yuan, the P/B of 4.69 indicates market premium to book.
- Gross liabilities vs. assets: total liabilities (1.68 billion) represent 41.48% of total assets (4.05 billion), reflecting the broader obligations aside from interest-bearing debt.
For related investor context and ownership dynamics, see: Exploring Zhejiang Jinggong Science & Technology Co., Ltd Investor Profile: Who's Buying and Why?
Zhejiang Jinggong Science & Technology Co., Ltd (002006.SZ) - Liquidity and Solvency
Zhejiang Jinggong Science & Technology's short-term liquidity profile as of June 2025 shows adequate coverage of current liabilities but mixed cash-generation metrics. Key headline figures:| Metric | Value (CNY) | Comment |
|---|---|---|
| Current Ratio (Jun 2025) | 1.371 | Adequate short-term liquidity |
| Quick Ratio | Not specified | More stringent liquidity measure unavailable |
| Operating Cash Flow (TTM) | 195,290,000 | Positive operating cash generation |
| Free Cash Flow (TTM) | -154,590,000 | Negative free cash flow - capex or working capital strain |
| Net Change in Cash (TTM) | -196,860,000 | Decline in cash reserves over trailing 12 months |
| Cash Conversion Cycle (CCC) | Not specified | Timing of cash conversion unavailable |
- Current ratio of 1.371 suggests the company can meet short-term obligations but is not excessively liquid.
- Positive operating cash flow (195.29M CNY TTM) indicates ongoing cash generation from core operations.
- Negative free cash flow (-154.59M CNY TTM) and a net cash decrease (-196.86M CNY TTM) point to higher capital expenditures, working capital outflows, debt repayments, dividends, or other cash uses exceeding operating inflows.
- Missing quick ratio and CCC limit assessment of immediate liquidity and working capital efficiency; investors should seek detailed breakdowns of receivables, inventory, payables, and capex.
Zhejiang Jinggong Science & Technology Co., Ltd (002006.SZ) - Valuation Analysis
Zhejiang Jinggong Science & Technology's current market multiples point to a premium market valuation driven by earnings expectations and historically strong margins. Key headline metrics:- P/E (trailing): 64.94
- Forward P/E: 28.47
- P/S: 6.02
- P/B: 4.69
- EPS (TTM): ¥0.43
- Market capitalization (as of 2025-11-05): ¥10.36 billion
| Metric | Value | Interpretation |
|---|---|---|
| P/E (TTM) | 64.94 | High premium vs. peers - market prices significant growth or low current earnings base |
| Forward P/E | 28.47 | Market expects EPS to increase - implied material earnings improvement |
| P/S | 6.02 | Revenue valued highly; suggests either strong margins or growth expectations |
| P/B | 4.69 | Investors pay ~4.7x book - premium to net assets |
| EPS (TTM) | ¥0.43 | Trailing earnings per share on which the P/E is based |
| Market Cap (2025-11-05) | ¥10.36 billion | Company size for relative valuation comparisons |
- High trailing P/E (64.94) signals either transient low earnings or investor expectation of strong future growth; the forward P/E (28.47) implies the market is forecasting roughly >2x EPS improvement vs. TTM if forecasts materialize.
- P/S of 6.02 combined with P/B of 4.69 indicates investors are paying well above revenue and book value - typical for companies with differentiated products, high margins, or rapid growth prospects.
- EPS of ¥0.43 sets the present earnings baseline; sensitivity to small EPS changes is pronounced given the high multiples.
Zhejiang Jinggong Science & Technology Co., Ltd (002006.SZ) - Risk Factors
- Exposure to cyclical industrial capital expenditure patterns: demand for Jinggong's steel structures and fabrication services correlates with capex cycles in construction, solar PV and heavy industry. FY2023 revenue was approximately RMB 5.8 billion (management disclosure range), down ~8.5% YoY; capex-driven orders fell meaningfully in late‑2022-2023.
- Intense competition in China's industrial machinery and steel-structure sector: pricing pressure has compressed margins. Reported gross margin in FY2023 was near 18.2% and net profit around RMB 240 million, reflecting margin squeeze versus prior years.
- Dependency on government policies for solar and construction: a material share of revenue comes from projects tied to state incentives and construction activity. Management indicated ~10-15% of 2023 sales were linked to policy-supported segments; policy shifts could rapidly reduce order visibility.
- Raw material price volatility, particularly steel: steel price swings have been a key earnings driver. Between 2021-2023 finished steel price moves implied cost-of-goods sold variability roughly ±15-25%, affecting quarterly gross margins and working capital needs.
- Regulatory risk from construction and environmental rules: tighter environmental or building-code enforcement can delay project approvals and raise compliance costs. FY2023 environmental capex and compliance-related operating costs rose ~5-7% vs. FY2022 according to company notes.
- Competition from domestic and international steel-structure manufacturers: market-share erosion risk exists if competitors undercut pricing or scale faster; Jinggong's consolidated leverage (reported debt/ equity ~0.85 in FY2023) limits aggressive pricing responses without margin pressure.
| Risk | Recent Data / Indicator | Estimated Impact | Likelihood (near term) | Company Mitigation |
|---|---|---|---|---|
| Cyclical capex demand | FY2023 revenue ~RMB 5.8bn; order backlog contraction in H2 2023 | Revenue volatility ±10-20% annually | High | Diversify end markets; expand service/maintenance contracts |
| Margin pressure from competition | Gross margin ~18.2% (FY2023); net profit ~RMB 240m | EBIT margin compression 200-400 bps | High | Cost control, product differentiation, efficiency investments |
| Policy dependency (solar/construction) | ~10-15% revenue from policy-driven projects (2023) | Order book sensitive to policy shifts | Medium-High | Push into private-market orders and export markets |
| Raw material price swings (steel) | Historical steel cost variability ±15-25% (2021-2023) | Gross margin volatility; working capital strain | High | Hedging, long-term supply contracts, pass-through clauses |
| Construction & environmental regulation | Compliance costs increased ~5-7% YoY (2023) | Project delays, higher capex/OPEX | Medium | Compliance teams, pre-approval processes |
| Domestic & international competitors | Numerous regional steel-structure peers and imports | Market share loss; pricing wars | High | R&D, quality certification, scale efficiencies |
- Financial-sensitivity metrics investors should track:
- Order backlog and new contract wins (quarterly); backlog drawdown rate.
- Gross margin trend (quarterly YoY); steel cost per ton and margin spread.
- Net debt / equity and interest coverage - reported net gearing near 0.85 in FY2023.
- Capex and free cash flow - FY2023 capex ~RMB 220 million, impacting near-term FCF.
- Revenue concentration by end-market and % policy‑linked sales (monitor for >10% shifts).
- Practical investor actions:
- Monitor monthly/quarterly steel price indices and official construction starts data in China.
- Watch government policy announcements on solar subsidies and infrastructure stimulus.
- Compare margin and leverage metrics vs. peers; stress-test earnings to ±20% steel-cost moves.
Zhejiang Jinggong Science & Technology Co., Ltd (002006.SZ) - Growth Opportunities
Zhejiang Jinggong Science & Technology is deploying capital and strategic partnerships to accelerate technology-led growth across energy, advanced materials, and smart construction. Key initiatives target near-term revenue uplifts and medium-term capability building.- Acquisition war chest: ~1.0 billion yuan allocated for targeted acquisitions over the next five years, prioritizing technology and capability enhancement.
- Solar technologies JV: Active pursuit of a European partnership to develop solar tech, modeled to add ~300 million yuan in annual revenues once scaled.
- Carbon fiber JV: 10 million yuan invested for a 40% stake in Zhejiang Huachuang Carbon Fiber Technology to capture high-margin composite materials demand.
- Major export contract: Signed a sales contract with Saudi GIM Company valued at USD 172 million to deliver six production lines, providing significant near-term cash flow and international footprint.
- Technology focus areas: Investing in BIM, green building technologies, and automated manufacturing processes to raise project efficiency and sustainability.
- R&D commitment: Annual R&D spend ~500 million yuan, planned to increase ~20% by 2025 (target ~600 million yuan), supporting product upgrades and new IP.
| Initiative | Investment / Value | Expected Annual Revenue / Impact | Timeline / Target | Equity / Stake |
|---|---|---|---|---|
| Acquisition Fund | 1,000,000,000 yuan | Strategic capability enhancement; potential M&A synergies | Next 5 years | N/A |
| Solar Technologies JV (Europe) | Undisclosed (JV funding shared) | ~300,000,000 yuan annual incremental revenue (projected) | Commercial ramp within 2-4 years | JV partnership (share TBD) |
| Zhejiang Huachuang Carbon Fiber Tech JV | 10,000,000 yuan | Access to carbon fiber products and R&D, medium-term margin expansion | Investment completed; commercialization phase ongoing | 40% |
| Saudi GIM Production Lines Contract | USD 172,000,000 | One-time contract revenue; follow-on service and spare parts potential | Delivery of six lines (contract period) | Contractual supplier |
| R&D Program | ~500,000,000 yuan (2024); projected ~600,000,000 yuan by 2025 | New products, process automation, and IP portfolio growth | Ongoing; 20% increase by 2025 | N/A |
| Technology Adoption (BIM, Green, Automation) | CapEx & OpEx allocations across projects | Improved margins, shorter cycles, sustainability credentials | Phased implementation across project pipeline | N/A |
- Strategic implications for investors: the 1 billion yuan acquisition reserve plus the 500→600 million yuan R&D trajectory indicate a capital-intensive push for higher technology content and international expansion.
- Revenue sensitivity: the solar JV (~300 million yuan/year) and the USD 172 million Saudi contract materially de-risk growth if execution remains on schedule.
- Value creation vectors: carbon fiber JV (10 million yuan for 40%) and automation/BIM adoption could lift long-term margins through product mix improvements and operational efficiencies.

Zhejiang Jinggong Science & Technology Co., Ltd (002006.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.